Agile Therapeutics (NDAQ:AGRX) Hit By Janney Capital Downgrade; Trustco Bank N Y Has 1.75 Sentiment

TrustCo Bank Corp NY operates as the holding firm for Trustco Bank that provides personal and business banking services to individuals, partnerships, and firms. The company has market cap of $881.79 million. The firm is primarily involved in accepting deposits, and making loans and investments. It has a 18.96 P/E ratio. It also operates as a real estate investment trust that acquires, holds, and manages real estate mortgage assets, including residential mortgage loans and mortgage backed securities.

Among 3 analysts covering Agile Therapeutics (NDAQ:AGRX), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Agile Therapeutics has $10 highest and $8 lowest target. $9.33’s average target is 210.36% above currents $362 stock price. Agile Therapeutics had 4 analyst reports since April 5, 2017 according to SRatingsIntel. The stock has “Buy” rating by H.C. Wainwright on Wednesday, July 19. The company was maintained on Thursday, September 14 by RBC Capital Markets. The rating was reinitiated by H.C. Wainwright with “Buy” on Monday, October 2.

Agile Therapeutics, Inc., a forward-thinking women's healthcare company, focuses on the development and commercialization of prescription contraceptive products for women. The company has market cap of $102.77 million. The Company’s lead product candidate is Twirla, also known as AG200-15, a once-weekly contraceptive patch, which completed Phase III clinical trials. It currently has negative earnings. The firm is also developing a pipeline of other new transdermal contraceptive products, including AG200-ER, a regimen that allows a woman to extend the length of her cycle; AG200-SP, which is a regimen designed to provide shorter lighter periods; and AG890, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen.

Investors sentiment increased to 1.35 in Q3 2017. Its up 0.74, from 0.61 in 2017Q2. It is positive, as 9 investors sold Agile Therapeutics, Inc. shares while 8 reduced holdings. 11 funds opened positions while 12 raised stakes. 23.16 million shares or 7.44% more from 21.56 million shares in 2017Q2 were reported. Art Advsrs reported 15,512 shares. Franklin Resource Incorporated invested in 2.77 million shares or 0.01% of the stock. Moreover, Parametric Port Assoc Ltd Company has 0% invested in Agile Therapeutics, Inc. (NASDAQ:AGRX). 9,323 are owned by Glenmede Com Na. Royal Commercial Bank Of Canada accumulated 135,820 shares. Moreover, Caxton Corporation has 8.26% invested in Agile Therapeutics, Inc. (NASDAQ:AGRX). Neuberger Berman Limited Liability Company has invested 0% in Agile Therapeutics, Inc. (NASDAQ:AGRX). Meeder Asset Management owns 1,649 shares for 0% of their portfolio. Janney Montgomery Scott Limited Liability Corp stated it has 35,500 shares. Blackrock invested in 0% or 108,891 shares. Great Point Prtnrs Ltd Liability Corporation stated it has 0.32% of its portfolio in Agile Therapeutics, Inc. (NASDAQ:AGRX). Northern holds 28,097 shares or 0% of its portfolio. Aisling Capital has 1.32% invested in Agile Therapeutics, Inc. (NASDAQ:AGRX) for 1.80M shares. Alyeska Invest Group Inc Lp holds 0.03% or 840,169 shares in its portfolio. Cormorant Asset Ltd Limited Liability Company accumulated 0.98% or 1.25M shares.

The stock increased 19.29% or $0.4862 during the last trading session, reaching $3.0062. About 1.91M shares traded or 351.88% up from the average. Agile Therapeutics, Inc. (NDAQ:AGRX) has declined 48.71% since December 26, 2016 and is downtrending. It has underperformed by 65.41% the S&P500.

Analysts await Agile Therapeutics, Inc. (NASDAQ:AGRX) to report earnings on March, 14. They expect $-0.25 earnings per share, up 13.79% or $0.04 from last year’s $-0.29 per share. After $-0.22 actual earnings per share reported by Agile Therapeutics, Inc. for the previous quarter, Wall Street now forecasts 13.64% negative EPS growth.

Trustco Bank Corp N Y holds 9.13% of its portfolio in TrustCo Bank Corp NY for 1.06 million shares. Nj State Employees Deferred Compensation Plan owns 170,000 shares or 0.27% of their US portfolio. Moreover, Jbf Capital Inc. has 0.26% invested in the company for 260,000 shares. The New York-based Adirondack Research & Management Inc. has invested 0.21% in the stock. Systematic Financial Management Lp, a New Jersey-based fund reported 945,491 shares.

The stock increased 0.27% or $0.025 during the last trading session, reaching $9.175. About 43,871 shares traded. TrustCo Bank Corp NY (TRST) has risen 18.11% since December 26, 2016 and is uptrending. It has outperformed by 1.41% the S&P500.